BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12734341)

  • 41. Spatial distribution of histone methylation during MHC class II expression.
    Chou SD; Tomasi TB
    Mol Immunol; 2008 Feb; 45(4):971-80. PubMed ID: 17850872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA.
    van den Elsen PJ; van der Stoep N; Viƫtor HE; Wilson L; van Zutphen M; Gobin SJ
    Hum Immunol; 2000 Sep; 61(9):850-62. PubMed ID: 11053628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells.
    Rigaud G; De Lerma Barbaro A; Nicolis M; Cestari T; Ramarli D; Riviera AP; Accolla RS
    J Immunol; 1996 Jun; 156(11):4254-8. PubMed ID: 8666795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-gamma).
    Kadota Y; Okumura M; Miyoshi S; Kitagawa-Sakakida S; Inoue M; Shiono H; Maeda Y; Kinoshita T; Shirakura R; Matsuda H
    Clin Exp Immunol; 2000 Jul; 121(1):59-68. PubMed ID: 10886240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein.
    O'Keefe GM; Nguyen VT; Ping Tang LL; Benveniste EN
    J Immunol; 2001 Feb; 166(4):2260-9. PubMed ID: 11160280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential selectivity of CIITA promoter activation by IFN-gamma and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-alpha.
    Nikcevich KM; Piskurich JF; Hellendall RP; Wang Y; Ting JP
    J Neuroimmunol; 1999 Oct; 99(2):195-204. PubMed ID: 10505975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Class II transactivator (CIITA) isoform expression and activity in melanoma.
    Baton F; Deruyffelaere C; Chapin M; Prod'homme T; Charron D; Al-Daccak R; Alcaide-Loridan C
    Melanoma Res; 2004 Dec; 14(6):453-61. PubMed ID: 15577315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of gene expression by the MHC class II transactivator.
    Nagarajan UM; Bushey A; Boss JM
    J Immunol; 2002 Nov; 169(9):5078-88. PubMed ID: 12391224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.
    van der Stoep N; Quinten E; Alblas G; Plancke A; van Eggermond MC; Holling TM; van den Elsen PJ
    Mol Immunol; 2007 Mar; 44(8):2036-46. PubMed ID: 17067677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
    Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
    Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
    Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
    Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.
    Steimle V; Siegrist CA; Mottet A; Lisowska-Grospierre B; Mach B
    Science; 1994 Jul; 265(5168):106-9. PubMed ID: 8016643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polycomb recruitment at the Class II transactivator gene.
    Boyd NH; Morgan JE; Greer SF
    Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression.
    Peijnenburg A; Gobin SJ; van Eggermond MC; Godthelp BC; van Graafeiland N; van den Elsen PJ
    J Immunol; 1997 Sep; 159(6):2720-7. PubMed ID: 9300692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control.
    Morris AC; Spangler WE; Boss JM
    J Immunol; 2000 Apr; 164(8):4143-9. PubMed ID: 10754309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.
    Masternak K; Muhlethaler-Mottet A; Villard J; Zufferey M; Steimle V; Reith W
    Genes Dev; 2000 May; 14(9):1156-66. PubMed ID: 10809673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator.
    Pai RK; Askew D; Boom WH; Harding CV
    J Immunol; 2002 Aug; 169(3):1326-33. PubMed ID: 12133955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CIITA activates the expression of MHC class II genes in mouse T cells.
    Chang CH; Hong SC; Hughes CC; Janeway CA; Flavell RA
    Int Immunol; 1995 Sep; 7(9):1515-8. PubMed ID: 7495759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant.
    Zhou H; Su HS; Zhang X; Douhan J; Glimcher LH
    J Immunol; 1997 May; 158(10):4741-9. PubMed ID: 9144488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.